Skip to main content
NCBI home page
Biochemical Journal logoLink to Biochemical Journal
. 1999 Nov 15;344(Pt 1):7–13.

Apolipoprotein serum amyloid A down-regulates smooth-muscle cell lipid biosynthesis.

B M Schreiber 1, M Veverbrants 1, R E Fine 1, J K Blusztajn 1, M Salmona 1, A Patel 1, J D Sipe 1
PMCID: PMC1220607  PMID: 10548527

Abstract

The addition of acute-phase apolipoprotein serum amyloid A (SAA) to cultured aortic smooth-muscle cells caused a decrease in the incorporation of [(14)C]acetate into lipids. Optimal inhibition of lipid biosynthesis was achieved with 2 microM SAA, and the effect was maintained for up to 1 week when SAA was included in the culture medium. Lipid extracts were subjected to TLC and it was determined that the SAA-induced decrease in [(14)C]acetate incorporation into lipids was attributable to decreases in cholesterol, phospholipid and triglyceride levels. The accumulated mass of cholesterol and phospholipid in SAA-treated cultures was significantly less than that of controls, with no change in the accumulated protein. Moreover, SAA had no effect on either protein synthesis or DNA synthesis, suggesting that SAA specifically alters lipid synthesis. By using a peptide corresponding to the cholesterol-binding domain of acute-phase SAA (amino acids 1-18), it was shown that this region of the molecule was as effective as the full-length protein in decreasing lipid synthesis and the accumulation of cholesterol and phospholipid. The implications of these findings for atherosclerosis and Alzheimer's disease are discussed.

Full Text

The Full Text of this article is available as a PDF (283.1 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Badolato R., Johnston J. A., Wang J. M., McVicar D., Xu L. L., Oppenheim J. J., Kelvin D. J. Serum amyloid A induces calcium mobilization and chemotaxis of human monocytes by activating a pertussis toxin-sensitive signaling pathway. J Immunol. 1995 Oct 15;155(8):4004–4010. [PubMed] [Google Scholar]
  2. Badolato R., Wang J. M., Murphy W. J., Lloyd A. R., Michiel D. F., Bausserman L. L., Kelvin D. J., Oppenheim J. J. Serum amyloid A is a chemoattractant: induction of migration, adhesion, and tissue infiltration of monocytes and polymorphonuclear leukocytes. J Exp Med. 1994 Jul 1;180(1):203–209. doi: 10.1084/jem.180.1.203. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bausserman L. L., Sadaniantz A., Saritelli A. L., Martin V. L., Nugent A. M., Sady S. P., Herbert P. N. Time course of serum amyloid A response in myocardial infarction. Clin Chim Acta. 1989 Oct 16;184(3):297–305. doi: 10.1016/0009-8981(89)90063-6. [DOI] [PubMed] [Google Scholar]
  4. Berk B. C., Weintraub W. S., Alexander R. W. Elevation of C-reactive protein in "active" coronary artery disease. Am J Cardiol. 1990 Jan 15;65(3):168–172. doi: 10.1016/0002-9149(90)90079-g. [DOI] [PubMed] [Google Scholar]
  5. Brown M. S., Goldstein J. L. The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor. Cell. 1997 May 2;89(3):331–340. doi: 10.1016/s0092-8674(00)80213-5. [DOI] [PubMed] [Google Scholar]
  6. Casl M. T., Surina B., Glojnarić-Spasić I., Pape E., Jagarinec N., Kranjcević S. Serum amyloid A protein in patients with acute myocardial infarction. Ann Clin Biochem. 1995 Mar;32(Pt 2):196–200. doi: 10.1177/000456329503200212. [DOI] [PubMed] [Google Scholar]
  7. Clifton P. M., Mackinnon A. M., Barter P. J. Effects of serum amyloid A protein (SAA) on composition, size, and density of high density lipoproteins in subjects with myocardial infarction. J Lipid Res. 1985 Dec;26(12):1389–1398. [PubMed] [Google Scholar]
  8. Dinarello C. A. Induction of interleukin-1 and interleukin-1 receptor antagonist. Semin Oncol. 1997 Jun;24(3 Suppl 9):S9–81-S9-93. [PubMed] [Google Scholar]
  9. Gabay C., Genin B., Mentha G., Iynedjian P. B., Roux-Lombard P., Guerne P. A. IL-1 receptor antagonist (IL-1Ra) does not inhibit the production of C-reactive protein or serum amyloid A protein by human primary hepatocytes. Differential regulation in normal and tumour cells. Clin Exp Immunol. 1995 May;100(2):306–313. doi: 10.1111/j.1365-2249.1995.tb03669.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Goldstein J. L., Dana S. E., Brown M. S. Esterification of low density lipoprotein cholesterol in human fibroblasts and its absence in homozygous familial hypercholesterolemia. Proc Natl Acad Sci U S A. 1974 Nov;71(11):4288–4292. doi: 10.1073/pnas.71.11.4288. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Gottfries C. G., Karlsson I., Svennerholm L. Membrane components separate early-onset Alzheimer's disease from senile dementia of the Alzheimer type. Int Psychogeriatr. 1996 Fall;8(3):365–372. doi: 10.1017/s1041610296002736. [DOI] [PubMed] [Google Scholar]
  12. Hachem H., Favre G., Soula G. Evidence for qualitative abnormalities in high-density lipoproteins from myeloma patients: the presence of amyloid A protein could explain HDL modifications. Biochim Biophys Acta. 1988 Nov 25;963(2):271–277. doi: 10.1016/0005-2760(88)90291-3. [DOI] [PubMed] [Google Scholar]
  13. Hussain M. M., Bucher N. L., Faris B., Franzblau C., Zannis V. I. Tissue-specific posttranslational modification of rat apoE. Synthesis of sialated apoE forms by neonatal rat aortic smooth muscle cells. J Lipid Res. 1988 Jul;29(7):915–923. [PubMed] [Google Scholar]
  14. Kisilevsky R., Subrahmanyan L. Serum amyloid A changes high density lipoprotein's cellular affinity. A clue to serum amyloid A's principal function. Lab Invest. 1992 Jun;66(6):778–785. [PubMed] [Google Scholar]
  15. Kumon Y., Sipe J. D., Brinckerhoff C. E., Schreiber B. M. Regulation of extrahepatic apolipoprotein serum amyloid A (ApoSAA) gene expression by interleukin-1 alpha alone: synthesis and secretion of ApoSAA by cultured aortic smooth muscle cells. Scand J Immunol. 1997 Sep;46(3):284–291. doi: 10.1046/j.1365-3083.1997.d01-128.x. [DOI] [PubMed] [Google Scholar]
  16. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  17. Liang J. S., Schreiber B. M., Salmona M., Phillip G., Gonnerman W. A., de Beer F. C., Sipe J. D. Amino terminal region of acute phase, but not constitutive, serum amyloid A (apoSAA) specifically binds and transports cholesterol into aortic smooth muscle and HepG2 cells. J Lipid Res. 1996 Oct;37(10):2109–2116. [PubMed] [Google Scholar]
  18. Liang J. S., Sipe J. D. Recombinant human serum amyloid A (apoSAAp) binds cholesterol and modulates cholesterol flux. J Lipid Res. 1995 Jan;36(1):37–46. [PubMed] [Google Scholar]
  19. Liang J. S., Sloane J. A., Wells J. M., Abraham C. R., Fine R. E., Sipe J. D. Evidence for local production of acute phase response apolipoprotein serum amyloid A in Alzheimer's disease brain. Neurosci Lett. 1997 Apr 4;225(2):73–76. doi: 10.1016/s0304-3940(97)00196-1. [DOI] [PubMed] [Google Scholar]
  20. Liao F., Andalibi A., Qiao J. H., Allayee H., Fogelman A. M., Lusis A. J. Genetic evidence for a common pathway mediating oxidative stress, inflammatory gene induction, and aortic fatty streak formation in mice. J Clin Invest. 1994 Aug;94(2):877–884. doi: 10.1172/JCI117409. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Liao F., Andalibi A., deBeer F. C., Fogelman A. M., Lusis A. J. Genetic control of inflammatory gene induction and NF-kappa B-like transcription factor activation in response to an atherogenic diet in mice. J Clin Invest. 1993 Jun;91(6):2572–2579. doi: 10.1172/JCI116495. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Liao F., Lusis A. J., Berliner J. A., Fogelman A. M., Kindy M., de Beer M. C., de Beer F. C. Serum amyloid A protein family. Differential induction by oxidized lipids in mouse strains. Arterioscler Thromb. 1994 Sep;14(9):1475–1479. doi: 10.1161/01.atv.14.9.1475. [DOI] [PubMed] [Google Scholar]
  23. Linke R. P., Bock V., Valet G., Rothe G. Inhibition of the oxidative burst response of N-formyl peptide-stimulated neutrophils by serum amyloid-A protein. Biochem Biophys Res Commun. 1991 May 15;176(3):1100–1105. doi: 10.1016/0006-291x(91)90397-p. [DOI] [PubMed] [Google Scholar]
  24. Liuzzo G., Biasucci L. M., Gallimore J. R., Grillo R. L., Rebuzzi A. G., Pepys M. B., Maseri A. The prognostic value of C-reactive protein and serum amyloid a protein in severe unstable angina. N Engl J Med. 1994 Aug 18;331(7):417–424. doi: 10.1056/NEJM199408183310701. [DOI] [PubMed] [Google Scholar]
  25. Lopez J. M., Bennett M. K., Sanchez H. B., Rosenfeld J. M., Osborne T. F. Sterol regulation of acetyl coenzyme A carboxylase: a mechanism for coordinate control of cellular lipid. Proc Natl Acad Sci U S A. 1996 Feb 6;93(3):1049–1053. doi: 10.1073/pnas.93.3.1049. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Majesky M. W., Benditt E. P., Schwartz S. M. Expression and developmental control of platelet-derived growth factor A-chain and B-chain/Sis genes in rat aortic smooth muscle cells. Proc Natl Acad Sci U S A. 1988 Mar;85(5):1524–1528. doi: 10.1073/pnas.85.5.1524. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Majesky M. W., Giachelli C. M., Reidy M. A., Schwartz S. M. Rat carotid neointimal smooth muscle cells reexpress a developmentally regulated mRNA phenotype during repair of arterial injury. Circ Res. 1992 Oct;71(4):759–768. doi: 10.1161/01.res.71.4.759. [DOI] [PubMed] [Google Scholar]
  28. Malle E., De Beer F. C. Human serum amyloid A (SAA) protein: a prominent acute-phase reactant for clinical practice. Eur J Clin Invest. 1996 Jun;26(6):427–435. doi: 10.1046/j.1365-2362.1996.159291.x. [DOI] [PubMed] [Google Scholar]
  29. Marhaug G., Hårklau L., Olsen B., Husby G., Husebekk A., Wang H. Serum amyloid A protein in acute myocardial infarction. Acta Med Scand. 1986;220(4):303–306. doi: 10.1111/j.0954-6820.1986.tb02769.x. [DOI] [PubMed] [Google Scholar]
  30. Maury C. P., Tötterman K. J., Gref C. G., Ehnholm C. Serum amyloid A protein, apolipoprotein A-I, and apolipoprotein B during the course of acute myocardial infarction. J Clin Pathol. 1988 Dec;41(12):1263–1268. doi: 10.1136/jcp.41.12.1263. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Meek R. L., Eriksen N., Benditt E. P. Murine serum amyloid A3 is a high density apolipoprotein and is secreted by macrophages. Proc Natl Acad Sci U S A. 1992 Sep 1;89(17):7949–7952. doi: 10.1073/pnas.89.17.7949. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Meek R. L., Urieli-Shoval S., Benditt E. P. Expression of apolipoprotein serum amyloid A mRNA in human atherosclerotic lesions and cultured vascular cells: implications for serum amyloid A function. Proc Natl Acad Sci U S A. 1994 Apr 12;91(8):3186–3190. doi: 10.1073/pnas.91.8.3186. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Mitchell T. I., Coon C. I., Brinckerhoff C. E. Serum amyloid A (SAA3) produced by rabbit synovial fibroblasts treated with phorbol esters or interleukin 1 induces synthesis of collagenase and is neutralized with specific antiserum. J Clin Invest. 1991 Apr;87(4):1177–1185. doi: 10.1172/JCI115116. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Nel A. E., De Beer M. C., Shephard E. G., Strachan A. F., Vandenplas M. L., De Beer F. C. Phosphorylation of human serum amyloid A protein by protein kinase C. Biochem J. 1988 Oct 1;255(1):29–34. doi: 10.1042/bj2550029. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Pruzanski W., de Beer F. C., de Beer M. C., Stefanski E., Vadas P. Serum amyloid A protein enhances the activity of secretory non-pancreatic phospholipase A2. Biochem J. 1995 Jul 15;309(Pt 2):461–464. doi: 10.1042/bj3090461. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Qiao J. H., Castellani L. W., Fishbein M. C., Lusis A. J. Immune-complex-mediated vasculitis increases coronary artery lipid accumulation in autoimmune-prone MRL mice. Arterioscler Thromb. 1993 Jun;13(6):932–943. doi: 10.1161/01.atv.13.6.932. [DOI] [PubMed] [Google Scholar]
  37. Qiao J. H., Xie P. Z., Fishbein M. C., Kreuzer J., Drake T. A., Demer L. L., Lusis A. J. Pathology of atheromatous lesions in inbred and genetically engineered mice. Genetic determination of arterial calcification. Arterioscler Thromb. 1994 Sep;14(9):1480–1497. doi: 10.1161/01.atv.14.9.1480. [DOI] [PubMed] [Google Scholar]
  38. Ridker P. M., Cushman M., Stampfer M. J., Tracy R. P., Hennekens C. H. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med. 1997 Apr 3;336(14):973–979. doi: 10.1056/NEJM199704033361401. [DOI] [PubMed] [Google Scholar]
  39. Rokita H., Loose L. D., Bartle L. M., Sipe J. D. Synergism of interleukin 1 and interleukin 6 induces serum amyloid A production while depressing fibrinogen: a quantitative analysis. J Rheumatol. 1994 Mar;21(3):400–405. [PubMed] [Google Scholar]
  40. Schreiber B. M., Jones H. V., Toselli P., Franzblau C. Long-term treatment of neonatal aortic smooth muscle cells with beta VLDL induces cholesterol accumulation. Atherosclerosis. 1992 Aug;95(2-3):201–210. doi: 10.1016/0021-9150(92)90023-a. [DOI] [PubMed] [Google Scholar]
  41. Schreiber B. M., Martin B. M., Hollander W., Franzblau C. beta-VLDL-induced alterations in growth potentiating activity produced by mononuclear phagocytes. Atherosclerosis. 1988 Jan;69(1):69–79. doi: 10.1016/0021-9150(88)90290-0. [DOI] [PubMed] [Google Scholar]
  42. Selinger M. J., McAdam K. P., Kaplan M. M., Sipe J. D., Vogel S. N., Rosenstreich D. L. Monokine-induced synthesis of serum amyloid A protein by hepatocytes. Nature. 1980 Jun 12;285(5765):498–500. doi: 10.1038/285498a0. [DOI] [PubMed] [Google Scholar]
  43. Shainkin-Kestenbaum R., Winikoff Y., Cristal N. Serum amyloid A concentrations during the course of acute ischaemic heart disease. J Clin Pathol. 1986 Jun;39(6):635–637. doi: 10.1136/jcp.39.6.635. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Shephard E. G., de Beer F. C., de Beer M. C., Jeenah M. S., Coetzee G. A., van der Westhuyzen D. R. Neutrophil association and degradation of normal and acute-phase high-density lipoprotein 3. Biochem J. 1987 Dec 15;248(3):919–926. doi: 10.1042/bj2480919. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Steinmetz A., Hocke G., Saïle R., Puchois P., Fruchart J. C. Influence of serum amyloid A on cholesterol esterification in human plasma. Biochim Biophys Acta. 1989 Nov 28;1006(2):173–178. doi: 10.1016/0005-2760(89)90192-6. [DOI] [PubMed] [Google Scholar]
  46. Stone M. J. Amyloidosis: a final common pathway for protein deposition in tissues. Blood. 1990 Feb 1;75(3):531–545. [PubMed] [Google Scholar]
  47. Su S. B., Gong W., Gao J. L., Shen W., Murphy P. M., Oppenheim J. J., Wang J. M. A seven-transmembrane, G protein-coupled receptor, FPRL1, mediates the chemotactic activity of serum amyloid A for human phagocytic cells. J Exp Med. 1999 Jan 18;189(2):395–402. doi: 10.1084/jem.189.2.395. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Svennerholm L., Gottfries C. G. Membrane lipids, selectively diminished in Alzheimer brains, suggest synapse loss as a primary event in early-onset form (type I) and demyelination in late-onset form (type II). J Neurochem. 1994 Mar;62(3):1039–1047. doi: 10.1046/j.1471-4159.1994.62031039.x. [DOI] [PubMed] [Google Scholar]
  49. Taga T., Kishimoto T. Gp130 and the interleukin-6 family of cytokines. Annu Rev Immunol. 1997;15:797–819. doi: 10.1146/annurev.immunol.15.1.797. [DOI] [PubMed] [Google Scholar]
  50. Tape C., Kisilevsky R. Apolipoprotein A-I and apolipoprotein SAA half-lives during acute inflammation and amyloidogenesis. Biochim Biophys Acta. 1990 Apr 17;1043(3):295–300. doi: 10.1016/0005-2760(90)90030-2. [DOI] [PubMed] [Google Scholar]
  51. Thyberg J., Hedin U., Sjölund M., Palmberg L., Bottger B. A. Regulation of differentiated properties and proliferation of arterial smooth muscle cells. Arteriosclerosis. 1990 Nov-Dec;10(6):966–990. doi: 10.1161/01.atv.10.6.966. [DOI] [PubMed] [Google Scholar]
  52. Tontonoz P., Kim J. B., Graves R. A., Spiegelman B. M. ADD1: a novel helix-loop-helix transcription factor associated with adipocyte determination and differentiation. Mol Cell Biol. 1993 Aug;13(8):4753–4759. doi: 10.1128/mcb.13.8.4753. [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Walker L. N., Bowen-Pope D. F., Ross R., Reidy M. A. Production of platelet-derived growth factor-like molecules by cultured arterial smooth muscle cells accompanies proliferation after arterial injury. Proc Natl Acad Sci U S A. 1986 Oct;83(19):7311–7315. doi: 10.1073/pnas.83.19.7311. [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. Xu L., Badolato R., Murphy W. J., Longo D. L., Anver M., Hale S., Oppenheim J. J., Wang J. M. A novel biologic function of serum amyloid A. Induction of T lymphocyte migration and adhesion. J Immunol. 1995 Aug 1;155(3):1184–1190. [PubMed] [Google Scholar]
  55. Yamada T., Kakihara T., Kamishima T., Fukuda T., Kawai T. Both acute phase and constitutive serum amyloid A are present in atherosclerotic lesions. Pathol Int. 1996 Oct;46(10):797–800. doi: 10.1111/j.1440-1827.1996.tb03552.x. [DOI] [PubMed] [Google Scholar]
  56. Zanellato A. M., Borrione A. C., Tonello M., Scannapieco G., Pauletto P., Sartore S. Myosin isoform expression and smooth muscle cell heterogeneity in normal and atherosclerotic rabbit aorta. Arteriosclerosis. 1990 Nov-Dec;10(6):996–1009. doi: 10.1161/01.atv.10.6.996. [DOI] [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES